Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients

Sex Transm Infect. 2017 May;93(3):229. doi: 10.1136/sextrans-2016-052922.

Authors

Chiara Santorelli¹, Cosimo Alex Leo², Franco Baldelli¹, Emanuel Cavazzoni¹

Affiliations

¹ Department of Surgery, University of Perugia, School of Medicine, Perugia, Italy.
² St Mark's Hospital Academic Institute, Harrow, Middlesex, UK.

PMID: 28432207
DOI: 10.1136/sextrans-2016-052922

No abstract available

Keywords: ANOGENITAL CANCER; CONDYLOMA; HIV; HPV; TREATMENT.

Publication types

Letter

MeSH terms

Administration, Topical
Adult
Aminoquinolines / administration & dosage
Aminoquinolines / adverse effects
Aminoquinolines / therapeutic use*
Anal Canal / drug effects
Anal Canal / virology
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Anus Neoplasms / complications
Anus Neoplasms / drug therapy*
Carcinoma in Situ / complications
Carcinoma in Situ / drug therapy
Condylomata Acuminata / complications
Condylomata Acuminata / diagnosis
Condylomata Acuminata / drug therapy*
Condylomata Acuminata / epidemiology
HIV Infections / complications*
HIV Infections / virology
Humans
Imiquimod
Italy / epidemiology
Male
Neoplasm Recurrence, Local / drug therapy
Neoplasm Recurrence, Local / virology
Retrospective Studies
Treatment Outcome

Substances

Aminoquinolines
Antineoplastic Agents
Imiquimod